PubRank

Robert F Kalejta

Author PubWeight™ 29.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 2006 2.32
2 Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 2012 2.02
3 Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 2008 1.99
4 Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. J Virol 2007 1.60
5 Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples. J Virol 2011 1.56
6 Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 2007 1.48
7 Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells. J Virol 2010 1.29
8 Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. Proc Natl Acad Sci U S A 2009 1.14
9 Cyclin-dependent kinase-like function is shared by the beta- and gamma- subset of the conserved herpesvirus protein kinases. PLoS Pathog 2010 1.10
10 Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div 2009 1.02
11 BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Proc Natl Acad Sci U S A 2012 1.01
12 Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae 2011 0.98
13 Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? Future Virol 2008 0.98
14 Ubiquitin-independent proteasomal degradation during oncogenic viral infections. Biochim Biophys Acta 2011 0.96
15 Tale of a tegument transactivator: the past, present and future of human CMV pp71. Future Virol 2012 0.94
16 Human embryonic stem cell lines model experimental human cytomegalovirus latency. MBio 2013 0.92
17 Human cytomegalovirus protein pp71 induces Daxx SUMOylation. J Virol 2009 0.90
18 Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations. J Virol 2013 0.89
19 Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication. MBio 2011 0.87
20 Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. J Virol 2013 0.85
21 Simian virus 40 T/t antigens and lamin A/C small interfering RNA rescue the phenotype of an Epstein-Barr virus protein kinase (BGLF4) mutant. J Virol 2010 0.84
22 Nuclear localization of tegument-delivered pp71 in human cytomegalovirus-infected cells is facilitated by one or more factors present in terminally differentiated fibroblasts. J Virol 2010 0.84
23 In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation. Methods 2011 0.83
24 Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency. J Virol 2013 0.82
25 Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particle. J Virol 2013 0.79
26 Insertion of myeloid-active elements into the human cytomegalovirus major immediate early promoter is not sufficient to drive its activation upon infection of undifferentiated myeloid cells. Virology 2013 0.76
27 Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk). ACS Chem Biol 2017 0.75